Skip to main content

Anne Prener

Equibles does not estimate personal net worth.

Get an email with a short summary when Damora Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get DMRA alerts

About Anne Prener

Anne Prener is recorded as Board Member at Damora Therapeutics, Inc. (DMRA) since January 8, 2021. Damora Therapeutics, Inc. reported in an 8-K filed November 10, 2025 that Anne Prener resigned as Board, effective November 10, 2025. Damora Therapeutics, Inc. reported in an 8-K filed January 8, 2021 that Anne Prener was appointed Class I director, effective January 8, 2021. Damora Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Damora Therapeutics, Inc. includes Jennifer Jarrett (CEO and Board Member), Sherwin Sattarzadeh (CEO and COO), Peter Harwin (Chairman and Board Member) and 7 others.

“Anne Prener, M.D., David Shapiro, M.D. and Amy Wechsler M.D. resigned from the Board and any respective committee of the Board to which they were members.”
Damora Therapeutics, Inc. Form 8-K, filed November 10, 2025 · Read the filing
“On January 7, 2021, the Board of Directors (the “Board”) of Galecto, Inc. (the “Company”), increased its size to nine directors and appointed Anne Prener to join the Board, effective as of January 8, 2021.”
Damora Therapeutics, Inc. Form 8-K, filed January 8, 2021 · Read the filing

Affiliation history

Company network

Leadership on record at Damora Therapeutics, Inc.

Recent activity